VECTORLOGICS INC has a total of 14 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology and pharmaceuticals are VERSEAU THERAPEUTICS INC, M S SWAMINATHAN RES FOUNDATION and SANDIG VOLKER.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Korokhov Nikolay | 12 |
#2 | Mikheeva Galina | 7 |
#3 | Kovesdi Imre | 2 |
#4 | Curiel David T | 1 |
#5 | Boureddini Sam C | 1 |
#6 | Hedley Susan J | 1 |
Publication | Filing date | Title |
---|---|---|
WO2009117656A2 | Capsid-incorporated antigen for novel adenovirus vaccine | |
EP2132300A2 | Cells for adenovirus vector and protein production | |
WO2006033999A2 | Modified adenovirus containing a fiber replacement protein | |
WO2006085913A2 | Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof | |
AU2003252118A1 | Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof | |
AU2003259199A1 | Adenoviral vector incorporating zipper peptide-modified fiber protein and uses thereof | |
WO02083880A1 | Mosaic adenoviral vectors |